Language

English

Publication Date

8-7-2025

Journal

The Journal of Clinical Endocrinology and Metabolism

DOI

10.1210/clinem/dgae916

PMID

39761818

PMCID

PMC12342374

PubMedCentral® Posted Date

1-7-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Context: Transitions in metabolic health status over time are strongly linked to risk for cardiovascular events, particularly among individuals with obesity. Adipokines are proteins with metabolic effects, but their role in transitions in metabolic health status over time is unknown.

Objective: To evaluate the associations of adiponectin and leptin with metabolic risk transitions over time.

Methods: Among 8423 individuals who attended ARIC Visits 2 (1990-1992) and 4 (1996-1998), we evaluated prospective associations of Visit 2 levels of the adipokines adiponectin and leptin (per 1-SD higher) with 6-year transitions in metabolic health. Metabolic health was categorized as metabolically "healthy" [no metabolic syndrome (MetS) or diabetes], unhealthy (MetS present) without diabetes, or unhealthy with diabetes. Analyses were performed overall and stratified by obesity [body mass index (BMI) ≥ 30 kg/m2].

Results: At Visit 2, the mean age was 58, with 56% female and 21% Black adults. Adults with 1-SD higher adiponectin were less likely to progress from metabolically healthy to unhealthy status over 6 years [odds ratio (OR) 0.53, 95% confidence interval (CI): 0.48-0.57], while those with higher leptin were more likely to progress (OR 2.22, 95% CI: 2.01-2.47). Conversely, those with 1-SD higher adiponectin were more likely to regress from metabolically unhealthy to healthy status (OR 1.58, 95% CI: 1.42-1.76), while those with higher leptin were less likely to regress (OR 0.68, 95% CI: 0.60-0.78). Similar patterns were seen across obesity strata. After adjustment for BMI, associations of adiponectin with metabolic transitions were similar, whereas associations for leptin were significantly attenuated.

Conclusion: Leptin and adiponectin are differentially linked to the likelihood of worsening and improving metabolic health over time. Adipokines should be explored as targets to improve metabolic health and decrease the risk of future cardiovascular events.

Keywords

Humans, Female, Male, Middle Aged, Leptin, Adiponectin, Metabolic Syndrome, Atherosclerosis, Prospective Studies, Obesity, Aged, Body Mass Index, Adipokines, Risk Factors, Follow-Up Studies, Health Status, Biomarkers, adipokines, adiponectin, leptin, metabolic syndrome, diabetes, regression

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.